A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds LGNDLIGAND PHARMACEUTICALS

26 funds on our shelf carry LIGAND PHARMACEUTICALS — heaviest hand: PJP at 3.51% of its book.

FundWeightFund assetsShares held
PJPInvesco Pharmaceuticals ETF3.51%—63,180
PSCHInvesco S&P SmallCap Health Care ETFINDEX3.26%$178M18,959
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX1.94%$487M26,334
XSMOInvesco S&P SmallCap Momentum ETFINDEX1.91%$2.9B185,233
IHEiShares U.S. Pharmaceuticals ETFINDEX1.37%$1.6B70,959
RZGInvesco S&P SmallCap 600 Pure Growth ETFINDEX1.28%$121M5,132
SLYGState Street SPDR S&P 600 Small Cap Growth ETFINDEX0.72%$4.8B115,582
VIOGVanguard S&P Small-Cap 600 Growth ETFINDEX0.72%$954M24,813
IJTiShares S&P Small-Cap 600 Growth ETFINDEX0.64%$7.7B185,713
QQQSInvesco NASDAQ Future Gen 200 ETFINDEX0.55%$10M422
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX0.46%$411M6,135
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.41%$112M1,437
IWOiShares Russell 2000 Growth ETFINDEX0.40%$14.4B188,363
QVMSInvesco S&P SmallCap 600 QVM Multi-factor ETFINDEX0.38%$239M2,983
XJRiShares ESG Screened S&P Small-Cap ETFINDEX0.36%$207M2,738
ESIXSPDR S&P SmallCap 600 ESG ETFINDEX0.36%—126
VTWGVanguard Russell 2000 Growth ETFINDEX0.35%$1B21,924
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETFINDEX0.34%$16B181,569
IJRiShares Core S&P Small-Cap ETFINDEX0.32%$104.3B1,219,894
VIOOVanguard S&P Small-Cap 600 ETFINDEX0.32%$2.9B72,152
RSSLGlobal X Russell 2000 ETFINDEX0.20%$1.5B9,536
IWMiShares Russell 2000 ETFINDEX0.20%$79.3B523,075
SMLFiShares MSCI USA Small-Cap Multifactor ETFINDEX0.19%$4.1B27,794
VTWOVanguard Russell 2000 ETFINDEX0.18%$9.9B115,446
SMMViShares MSCI USA Small-Cap Min Vol Factor ETFINDEX0.09%$270M926
VHTVanguard Health Care Index FundINDEX0.08%$19B59,640

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.